News & Updates
Filter by Specialty:

RUBY update: Dostarlimab strengthens spot in the endometrial cancer treatment arena
30 Jul 2024
byAudrey Abella
The addition of dostarlimab to a carboplatin-paclitaxel (CP) chemotherapy regimen confers an overall survival (OS) benefit in women with primary advanced or recurrent endometrial cancer (EC), according to the second interim analysis of the ENGOT-EN6/GOG-3031/RUBY trial part 1.
RUBY update: Dostarlimab strengthens spot in the endometrial cancer treatment arena
30 Jul 2024
Dual-function hydrogel implant helps stop endometriosis, pregnancy
29 Jul 2024
byJairia Dela Cruz
A novel, stimuli-responsive hydrogel implant for reversible occlusion of the fallopian tubes holds promise for preventing pregnancy and endometriosis or halting the latter’s spread, as reported in a study.